60 results
DEFA14A
TYRA
Tyra Biosciences Inc
7 May 24
Additional proxy soliciting materials
4:34pm
virtual meeting, which will be conducted via live webcast.
The primary purpose of this Supplement is to provide subsequent information relating
PRE 14A
TYRA
Tyra Biosciences Inc
5 Apr 24
Preliminary proxy
4:20pm
, and the information is not necessarily indicative of beneficial ownership for any other purpose. Except as indicated by the footnotes below, we believe, based … by that person or entity that are currently exercisable within 60 days of March 26, 2024. We did not deem these shares outstanding, however, for the purpose
S-8
TYRA
Tyra Biosciences Inc
19 Mar 24
Registration of securities for employees
4:35pm
by Exhibit 4.3 to our Annual Report on Form 10-K for the year ended December 31, 2021, and any amendments or reports filed for the purpose of updating
8-K
EX-4.1
nu9adcgcjjd9ee1cuo
5 Feb 24
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
6:05am
8-K
EX-10.1
0twqa5qp5re8ihosz3n
5 Feb 24
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
6:05am
8-K
EX-3.2
gra76342trpyuu
26 Oct 23
Amendments to Articles of Incorporation or Bylaws
4:50pm
8-K
EX-3.1
z7ar0wql9ihm
26 Oct 23
Amendments to Articles of Incorporation or Bylaws
4:50pm
8-K
EX-99.1
8rileyricpr7m5e
3 Nov 22
Tyra Biosciences Reports Third Quarter 2022 Financial Results and Highlights
4:16pm